{"id":"W4210876307","doi":"10.1016/j.neuropharm.2022.108985","title":"In vivo imaging of alpha-synuclein with antibody-based PET","year":2022,"lang":"en","type":"article","venue":"Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Brain Institute; University of Toronto; University Health Network","funders":"Parkinsonfonden; Uppsala Universitet; Vetenskapsrådet; Knut och Alice Wallenbergs Stiftelse; Science for Life Laboratory; Alzheimerfonden; Hjärnfonden; European Commission","keywords":"Radioligand; Antibody; Alpha-synuclein; Genetically modified mouse; Synucleinopathies; Chemistry; Positron emission tomography; In vivo; Preclinical imaging; Pet imaging; Pathology; Molecular biology; Transgene; Medicine; Nuclear medicine; Receptor; Parkinson's disease; Biology; Immunology; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003688282,0.0004800867,0.0002682679,0.0002722138,0.0001100315,0.000388023,0.0005024552,0.0007495604,0.0008548085],"category_scores_gemma":[0.000169038,0.0003470094,0.0002100432,0.0002815534,0.0001921318,0.0003246054,0.0002074954,0.0004984295,0.0003684825],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002443702,"about_ca_system_score_gemma":0.0001393583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000516435,"about_ca_topic_score_gemma":0.0005204327,"domain_scores_codex":[0.9998697,0.00005039257,0.000006771533,0.00003273115,0.00001876499,0.00002169949],"domain_scores_gemma":[0.9999497,0.00001598917,0.0000111357,0.000006025764,0.000009577618,0.000007644723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001415021,0.00002961506,0.0001024187,0.00007485487,0.00001218291,0.0001095802,0.00001117575,0.0003769939,0.9964897,0.0001750519,0.0001055819,0.002371264],"study_design_scores_gemma":[0.00008238234,0.001266651,0.003187702,0.00002385021,0.0001319066,0.00283575,0.00003214395,0.01216618,0.9699621,0.0002664485,0.01002101,0.00002396391],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7785908,0.02051733,0.1903371,0.0005097309,0.000117942,0.0003257948,0.0006404867,0.0006209642,0.008339813],"genre_scores_gemma":[0.8622962,0.01330835,0.1154371,0.0002761933,0.00007462479,0.0003218843,0.0009834211,0.0001348153,0.007167482],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008548085,"threshold_uncertainty_score":0.002859652,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01084205511959363,"score_gpt":0.2976274210765356,"score_spread":0.2867853659569419,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}